United States Vaccines Market Size & Forecast (2015 – 2026

through 2026.The report provides clear insight into current and future developments of the united states vaccines market. The report also explores the detailed analysis of the leading 27 vaccines market assessments in the United States from 2015 to 2018 and forecasts to 2026. A comprehensive analysis has been done on market share with percentage of the leading 27 vaccines. The report also details the latest information about the vaccine's pricing trends and regulatory framework of the United States vaccine market. Key trends in terms of collaboration, partnerships, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also examines the main market growth driving and restraining forces and also gives an all-round future outlook through 2026. The report concludes with the profiles of the key players in the united states vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, promising vaccines in the clinical development, and recent development.

The major companies dominating this market for its products, services, and continuous product developments are: • Pfizer • Merck • Sanofi Pasteur • Grifols • GlaxoSmithKline (GSK) • Dynavax Technologies Corporation The following 27 leading vaccines of the united states vaccines market are detailed with market size and seven-years forecast • Prevnar / Prevnar 13 • Gardasil / Gardasil 9 • Fluzone • Flublok • Flucelvax Quadrivalent